trending Market Intelligence /marketintelligence/en/news-insights/trending/-OL5T-oCQy82z8r67WMFdg2 content esgSubNav
In This List

Ziopharm raises $8.4M through private placement with investor

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Ziopharm raises $8.4M through private placement with investor

Ziopharm Oncology Inc. closed a private placement to raise gross proceeds of $8.4 million from an accredited investor.

The Boston-based biotechnology company, which develops and commercializes treatments for tumors and unknown antigens, issued 2,787,879 common shares at $3.01 each against the exercise of all remaining warrants held by the investor.

Additionally, Ziopharm issued new five-year warrants to purchase 2,787,879 additional shares to the investor, who can exercise the new warrants six months after the date of issue for $7 per share. The investor can only exercise the new warrants if its stake in the company does not exceed 9.99% of all outstanding shares. However, it can alter or terminate the ownership limit clause with a 61-day prior notice.

The placement closed Sept. 13.